https://scholars.lib.ntu.edu.tw/handle/123456789/620206
標題: | First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma | 作者: | Italiano A. Cassier P.A. CHIA-CHI LIN Alanko T. Peltola K.J. Gazzah A. Shiah H.-S. Calvo E. Cervantes A. Roda D. Tosi D. Gao B. Millward M. Warburton L. Tanner M. Englert S. Lambert S. Parikh A. Afar D.E. Vosganian G. Moreno V. |
公開日期: | 2022 | 出版社: | Springer Science and Business Media Deutschland GmbH | 卷: | 71 | 期: | 2 | 起(迄)頁: | 417-431 | 來源出版物: | Cancer Immunology, Immunotherapy | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109344549&doi=10.1007%2fs00262-021-02973-w&partnerID=40&md5=1460756dafddfaa1e2f33275c4f3423b https://scholars.lib.ntu.edu.tw/handle/123456789/620206 |
ISSN: | 0340-7004 | DOI: | 10.1007/s00262-021-02973-w |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。